Please be aware that this is a machine translation from French to English. AVICENN is not responsible for incorrect or inaccurate translations but welcomes suggestions for reformulation.

VeilleNanos - Benefit/risk analysis

Benefit/risk analysis

image
News
+ Info sheets
Agenda

Benefit/risk analyses of products containing nanos

By the AVICENN team – Last modification in April 2022

The benefit/risk analysis of products containing nanos must cover the whole life cycle of the products and integrate the impacts for all involved… especially the most vulnerable.

It is not only the health and environmental risks associated with nanomaterials that need to be carefully assessed.

The benefits of nanos also need to be seriously examined and evaluated.

For each type of product, the following questions arise:

  • What needs are nanomaterials supposed to meet?
  • What functions do they perform? Are they essential? Useful or futile? Who benefits (manufacturers / distributors / users)?
  • What evidence is there of the benefits described? Are they provided in understandable language? On a sales pitch or on a safety data sheet?
  • Do these pieces of information describe noticeable, perceptible and important benefits to you?
  • How are decisions made: who decides what, at what point in the innovation life cycle? Which stakeholders are impacted at each stage of the innovation life cycle? Have they been able to express an opinion and is it taken into account?
  • Is the use of nanomaterials limited, reserved for a confined professional environment?
  • Will the health, environmental and social impacts be significantly altered by a commercial extension to the general public?
  • Have the consequences of a generalization of these products integrating nanomaterials / nanotechnologies been simulated?
  • Have waste flow simulations been done?
  • Do alternatives exist? and are they more or less “effective” than the advertised properties related to “added nanos”?
Elsewhere on the web

In French :

In English:

Any questions or comments? This information sheet compiled by AVICENN is intended to be completed and updated. Please feel free to contribute.

Upcoming Nano Agenda

14
Avr.
2025
Advanced Characterization Techniques in Nanomaterials and Nanotechnology (Nano2025, Rome – Italy)
Rome
Congress
  • Advanced Characterization Techniques in Nanomaterials and Nanotechnology 
  • 10th European Congress on Advanced Nanotechnology and Nanomaterials
  • 14 and 15 April 2025
  • Website: https://nanomaterialsconference.com
13
Mai
2025
5th Joint Symposium on Nanotechnology (BfR & Fraunhofer Nanotechnology Network – Würzburg, Germany)
Würzburg
Conference
  • 5th Joint Symposium on Nanotechnology
  • Organizers: the Fraunhofer Nanotechnology Network, with the support of the Federal Institute for Risk Assessment (BfR)
  • Date: May 13-14, 2025
  • Topics:
    • the application of nanotechnology in various sectors, including digitalization, 2D/3D printing, carbon-based materials and battery materials
    • nano on various regulations (REACh, food contact materials, cosmetics, bioagents, PPPs)
    • adaptation and development of OECD Test Guidelines for nano and advanced materials (Malta Initiative)
    • review on nano-specific NAMs (new approach methodologies)
    • when you’re nano and you know it: dealing with uncertainty regarding the nanomaterial definition in regulatory frameworks
  • Website: www.isc.fraunhofer.de/…2025/5th-symposium-nanotechnology.html

19
Mai
2025
Toxicokinetics: the fate of chemicals in the body (ATC, Paris)
Paris
Training
  • 4-day training :
    • the different routes by which toxic substances can enter the body
    • the importance of toxicokinetics in preventing the toxicity of substances,
    • the absorption, distribution, metabolisation and elimination of xenobiotics
    • the toxicity of nanoparticles
  • Organizer : Association Toxicologie Chimie (ATC)
  • From May, 19 to May, 22
  • Speakers :
    • Frédéric Gaidou (Chemical engineer specialising in Toxicology, ERAMET Group, Paris, President ATC Paris)
    • Sarah Dognin dit Cruissat (Doctor of Pharmacy, nutritionist, toxicochemist, CALMEVA, Lyon)
    • Jean-Dominique Puyt (Veterinary Doctor, Honorary Professor at the École Vétérinaire, Nantes)
    • Isabelle Malissin (Doctor, Hôpital Lariboisière, Paris)
    • Nicole Proust (Research Engineer, Honorary Director of Research at the CNRS, Specialist in Nanotechnologies, Arsenic, Electromagnetic Waves, Palaiseau)
    • Marie-Chantal Canivenc-Lavier ((Nutri-toxicologist, Centre des Sciences du Goût et de l’Alimentation INRA-Dijon)
    • Claude Lesné (Doctor, Honorary Senior Research Engineer at the CNRS)
    • Nicole Proust (Ingénieure Recherche, Directeur de recherche honoraire du CNRS, Spécialiste Nanotechnologies, Arsenic, Ondes électromagnétiques, Palaiseau)
  • Website : https://www.atctoxicologie.fr/notre-formation.html

File initially put on line in October 2013


Our monitoring, information and actions need you to continue !